V-Erb B2紅白血病病毒癌基因同源物3(ErbB3)活性蛋白
Active V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3)
HER3; MDA-BF-1; C-ErbB3; LCCS2; ErbB3-S; P180-ErbB3; P45-SErbB3; P85-SErbB3; Receptor Tyrosine-Protein Kinase ErbB-3; Lethal Congenital Contracture Syndrome 2
- 編號(hào)APC187Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)6.6
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 暫無報(bào)價(jià) 暫無報(bào)價(jià) 暫無報(bào)價(jià) 暫無報(bào)價(jià) 暫無報(bào)價(jià)
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實(shí)驗(yàn)
V-Erb B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (ErbB3) is a member of the ErbB family of receptor tyrosine kinases. It is also known as human epidermal growth factor receptor 3 (HER3). ErbB3 plays a crucial role in various cellular processes including proliferation, differentiation, and survival. Neuregulin 1 (NRG1) is one of ligands of ErbB3, when NRG1 binds to ErbB3, it triggers dimerization and self-phosphorylation of the receptor, thereby activating downstream signaling pathways such as the PI3K/Akt and MAPK pathways. These signaling pathways are essential for cell growth and survival. Thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human ErbB3 and recombinant human NRG1. Briefly, NRG1 was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to ErbB3-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-NRG1 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μL stop solution to the wells and read at 450/630 nm immediately. When recombinant human ErbB3 is immobilized at 2 ug/mL (100 uL/well), the concentration of NRG1 that produces 50% optimal binding response is found to be approximately 0.14 ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APC187Hu01 | V-Erb B2紅白血病病毒癌基因同源物3(ErbB3)活性蛋白 | Cell?culture;?Activity?Assays. |
RPC187Hu01 | V-Erb B2紅白血病病毒癌基因同源物3(ErbB3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAC187Hu01 | V-Erb B2紅白血病病毒癌基因同源物3(ErbB3)多克隆抗體 | WB; IHC; ICC; IP. |
MAC187Hu21 | V-Erb B2紅白血病病毒癌基因同源物3(ErbB3)單克隆抗體 | WB; IHC; ICC; IP. |
SEC187Hu | V-Erb B2紅白血病病毒癌基因同源物3(ErbB3)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMC187Hu | V-Erb B2紅白血病病毒癌基因同源物3(ErbB3)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |